Literature DB >> 17364132

Detrusor overactivity does not predict outcome of sacral neuromodulation test stimulation.

Mary M T South1, Audrey A Romero, Margaret G Jamison, George D Webster, Cindy L Amundsen.   

Abstract

The aim of this study is to determine if urodynamic findings in patients with urge incontinence predicts response to sacral neuromodulation test stimulation. One hundred four patients with refractory urinary urge incontinence who had undergone sacral neuromodulation test stimulation were retrospectively reviewed. Pre- and post-test stimulation incontinence parameters and pelvic floor muscle (PFM) contraction strength was documented. Urodynamics were reviewed on all patients, and the presence or absence of detrusor overactivity (DO) was noted. Patients were then divided into two groups: responders to the test stimulation and non-responders. A positive response was considered to be a >or=50% improvement in the number of incontinent episodes per day (IE/day) and/or pad weight with test stimulation. Of the 104 patients evaluated, 64% (N = 67) responded to the test stimulation, while 36% (N = 37) were non-responders. The mean age was 59.7 and 67.0 among responders and non-responders (p = .01). There was a significant difference in the number of IE/day between non-responders and responders (p = .02). There was no relationship found between the presence or absence of DO and the likelihood for test stimulation success, patient demographics or pre test stimulation incontinence variables. Our study provides no statistically significant evidence that the presence or absence of DO on urodynamics predicts a response to sacral neuromodulation test stimulation. An important finding, however, was that patients without demonstrable DO on urodynamics may still have a positive response to sacral neuromodulation.

Entities:  

Mesh:

Year:  2007        PMID: 17364132     DOI: 10.1007/s00192-007-0351-7

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  12 in total

1.  Sacral nerve neuromodulation in the treatment of patients with refractory motor urge incontinence: long-term results of a prospective longitudinal study.

Authors:  J L Bosch; J Groen
Journal:  J Urol       Date:  2000-04       Impact factor: 7.450

2.  Urodynamic results of sacral neuromodulation correlate with subjective improvement in patients with an overactive bladder.

Authors:  W A Scheepens; G A van Koeveringe; R A de Bie; E H J Weil; Ph E V van Kerrebroeck
Journal:  Eur Urol       Date:  2003-03       Impact factor: 20.096

Review 3.  The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip Van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Urology       Date:  2003-01       Impact factor: 2.649

4.  Sacral neuromodulation for the treatment of refractory urinary urge incontinence after stress incontinence surgery.

Authors:  Neil D Sherman; Margaret G Jamison; George D Webster; Cindy L Amundsen
Journal:  Am J Obstet Gynecol       Date:  2005-12       Impact factor: 8.661

5.  Incontinence history as a predictor of detrusor stability.

Authors:  P K Sand; R C Hill; D R Ostergard
Journal:  Obstet Gynecol       Date:  1988-02       Impact factor: 7.661

6.  Conventional and ambulatory urodynamic findings in women with symptoms suggestive of bladder overactivity.

Authors:  S C Radley; D J Rosario; C R Chapple; A G Farkas
Journal:  J Urol       Date:  2001-12       Impact factor: 7.450

7.  Sacral neuromodulation for intractable urge incontinence: are there factors associated with cure?

Authors:  Cindy L Amundsen; Audrey A Romero; Margaret G Jamison; George D Webster
Journal:  Urology       Date:  2005-10       Impact factor: 2.649

8.  Predictors of success with neuromodulation in lower urinary tract dysfunction: results of trial stimulation in 100 patients.

Authors:  E L Koldewijn; P F Rosier; E J Meuleman; A M Koster; F M Debruyne; P E van Kerrebroeck
Journal:  J Urol       Date:  1994-12       Impact factor: 7.450

9.  The relationship between urinary symptom questionnaires and urodynamic diagnoses: an analysis of two methods of questionnaire administration.

Authors:  Mohid S Khan; Charlotte Chaliha; Lucia Leskova; Vikram Khullar
Journal:  BJOG       Date:  2004-05       Impact factor: 6.531

10.  Urodynamic classification of patients with symptoms of overactive bladder.

Authors:  Adam J Flisser; Konstantin Walmsley; Jerry G Blaivas
Journal:  J Urol       Date:  2003-02       Impact factor: 7.450

View more
  12 in total

Review 1.  Effectiveness of BTX-A and neuromodulation in treating OAB with or without detrusor overactivity: a systematic review.

Authors:  Suneetha Rachaneni; Pallavi Latthe
Journal:  Int Urogynecol J       Date:  2017-01-12       Impact factor: 2.894

2.  Surgical options for drug-refractory overactive bladder patients.

Authors:  Jonathan S Starkman; Christopher P Smith; David R Staskin
Journal:  Rev Urol       Date:  2010

3.  Role of botulinum toxin-A in refractory idiopathic overactive bladder patients without detrusor overactivity.

Authors:  Prashanth Kanagarajah; Rajinikanth Ayyathurai; Daniel J Caruso; Christopher Gomez; Angelo E Gousse
Journal:  Int Urol Nephrol       Date:  2011-06-04       Impact factor: 2.370

Review 4.  Urodynamics in the evaluation of overactive bladder.

Authors:  Eric S Rovner; Colin M Goudelocke
Journal:  Curr Urol Rep       Date:  2010-09       Impact factor: 3.092

Review 5.  Novel biomarkers for overactive bladder.

Authors:  Rufus Cartwright; Iram Afshan; Alexandros Derpapas; Gopalan Vijaya; Vik Khullar
Journal:  Nat Rev Urol       Date:  2011-02-15       Impact factor: 14.432

6.  Objective differences between overactive bladder patients with and without urodynamically proven detrusor overactivity.

Authors:  Michael L Guralnick; Gwen Grimsby; Michael Liss; Aniko Szabo; R Corey O'Connor
Journal:  Int Urogynecol J       Date:  2009-11-12       Impact factor: 2.894

7.  Algorithms for the management of overactive bladder.

Authors:  Richard T Kershen
Journal:  Curr Urol Rep       Date:  2009-09       Impact factor: 3.092

Review 8.  [Second-line therapy of idiopathic detrusor overactivity. Sacral neuromodulation and botulinum toxin A].

Authors:  B Amend; D Castro-Diaz; E Chartier-Kastler; D De Ridder; K Everaert; M Spinelli; P van Kereebroeck; K-D Sievert
Journal:  Urologe A       Date:  2010-02       Impact factor: 0.639

Review 9.  Neuromodulation for overactive bladder.

Authors:  Jamie Bartley; Jason Gilleran; Kenneth Peters
Journal:  Nat Rev Urol       Date:  2013-07-02       Impact factor: 14.432

10.  Clinical and urodynamic differences among women with overactive bladder according to the presence of detrusor overactivity.

Authors:  Seong Jin Jeong; Sang Cheol Lee; Chang Wook Jeong; Sung Kyu Hong; Seok-Soo Byun; Sang Eun Lee
Journal:  Int Urogynecol J       Date:  2012-05-16       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.